Vidhi Specialty Food Ingredients Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹146Cr
- +65.9% YoY
- +18.7% QoQ
- Net profit
- ₹17Cr
- +30.8% YoY
- +30.8% QoQ
- Margin
- 18%
- −5 pp YoY
- +1 pp QoQ
Guidance rank: #35 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Vidhi Specialty Food Ingredients Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1 FY27 Revenue from Operations: Rs. 146.3 Cr, up 66.4% YoY from Rs. 87.9 Cr in Q1 FY26 (Page 10, 13). Q1 FY27 EBITDA: Rs. 26.0 Cr., a 26.7% increase YoY from Rs. 20.5 Cr. in Q1 FY26.
From Vidhi Specialty Food Ingredients Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1 FY27 Revenue from Operations: Rs. 146.3 Cr, up 66.4% YoY from Rs. 87.9 Cr in Q1 FY26 (Page 10, 13).
- Q1 FY27 Total Sales Volume: 1,506.1 MT, up from 1,436.0 MT in Q1 FY26 (Page 10).
- Manufacturing Sales in Q1 FY27: Rs. 99.6 Cr; Trading Sales: Rs. 46.7 Cr (Page 11).
2 more points from Vidhi Specialty Food Ingredients Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Vidhi Specialty Food Ingredients Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capacity doubled from 325 MT to 675 MT per month with commencement of Dahej Plant in 2023 (Page 22).
- Planned capacity addition of 200 MT/month at Arjun Foods, Roha MIDC, in 2 phases for pharma and healthcare applications; pilot plant ready, product under sampling (Page 15).
- Planned capacity addition of 300 MT/month at newly acquired land in Dahej, in 2 phases for cosmetics, personal care, plastics, paints, coatings, inks, automotive, packaging, textiles, construction, security, electronics, and consumer devices; pilot plant ready, product sampling to begin soon (Page 15).
2 more points from Vidhi Specialty Food Ingredients Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vidhi Specialty Food Ingredients Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Vidhi Specialty Food Ingredients Ltd said on order book & pipeline — free account, 30 seconds.
Vidhi Specialty Food Ingredients Ltd — Quarterly revenue & net profit
Vidhi Specialty Food Ingredients Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 146 | 88 | +65.9% | 123 | +18.7% |
| Operating profit (EBITDA) | 26 | 21 | +23.8% | 21 | +23.8% |
| Operating margin | 18% | 23% | -5 pp | 17% | +1 pp |
| Profit before tax | 23 | 17 | +35.3% | 18 | +27.8% |
| Net profit (PAT) | 17 | 13 | +30.8% | 13 | +30.8% |
| EPS (₹) | 3.43 | 2.55 | +34.5% | 2.66 | +28.9% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹137 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vidhi Specialty's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q4 FY24 earnings call →
Earlier calls (1)
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Vidhi Specialty Food Ingredients Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vidhi Specialty Food Ingredients Ltd Q1 FY27 results?
Q1 FY27 Revenue from Operations: Rs. 146.3 Cr, up 66.4% YoY from Rs. 87.9 Cr in Q1 FY26 (Page 10, 13). Q1 FY27 EBITDA: Rs. 26.0 Cr., a 26.7% increase YoY from Rs. 20.5 Cr. in Q1 FY26.
What is Vidhi Specialty Food Ingredients Ltd share price analysis?
Vidhi Specialty Food Ingredients Ltd currently shows a neutral. The stock trades at a P/E of 32.1 with a market cap of ₹1,721 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vidhi Specialty Food Ingredients Ltd planning capital expenditure?
Capacity doubled from 325 MT to 675 MT per month with commencement of Dahej Plant in 2023 (Page 22).
Keep Vidhi Specialty Food Ingredients Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
